Spinal Muscular Atrophy A (Now) Treatable Neurodegenerative Disease

被引：6

作者：

Fay, Alex ^{[1
]}

机构：

[1] Univ Calif San Francisco, 1875 4th St,Suite 5A, San Francisco, CA 94158 USA

来源：

PEDIATRIC CLINICS OF NORTH AMERICA | 2023年 / 70卷 / 05期

关键词：

Spinal muscular atrophy; Gene therapy; Motor neuron disease; Newborn screening; WERDNIG-HOFFMANN DISEASE; PLACEBO-CONTROLLED TRIAL; NATURAL-HISTORY; VALPROIC ACID; DOUBLE-BLIND; SHAM CONTROL; ONSET; NUSINERSEN; CHILDHOOD; GENE;

D O I：

10.1016/j.pcl.2023.06.002

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

The last 6 years have brought transformative changes to the treatment of SMA, with three approved therapies that are lifesaving in the infantile period and life-altering across the age spectrum. Newborn screening will allow for the greatest benefit of each therapy, as treatment can be started in the pre-symptomatic period. Still, many patients will continue to have residual motor disability, so adjunctive therapies, combined therapies, and improved delivery of current treatments to motor neurons will be needed. The achievements in treating this neurodegenerative disease offer hope for other, more rare forms of SMA, and for neurological diseases across the lifespan.

引用

页码：963 / 977

页数：15

共 83 条

[1] Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells [J].

Angelozzi, C. ;

Borgo, F. ;

Tiziano, F. D. ;

Martella, A. ;

Neri, G. ;

Brahe, C. .

JOURNAL OF MEDICAL GENETICS, 2008, 45 (01) :29-31

[2] A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy [J].

Barrett, Doreen ;

Bilic, Sanela ;

Chyung, Yung ;

Cote, Shaun M. ;

Iarrobino, Ryan ;

Kacena, Katherine ;

Kalra, Ashish ;

Long, Kimberly ;

Nomikos, George ;

Place, Amy ;

Still, James Gordon ;

Vrishabhendra, Leela .

ADVANCES IN THERAPY, 2021, 38 (06) :3203-3222

[3] A case of congenital spinal muscular atrophy (Family type), and a case of h ae morrhage into the spinal cord at birth, giving similar symptoms. [J].

Beevor, CE .

BRAIN, 1902, 25 :85-108

[4] Glucose metabolism and pancreatic defects in spinal muscular atrophy [J].

Bowerman, Melissa ;

Swoboda, Kathryn J. ;

Michalski, John-Paul ;

Wang, Gen-Sheng ;

Reeks, Courtney ;

Beauvais, Ariane ;

Murphy, Kelley ;

Woulfe, John ;

Screaton, Robert A. ;

Scott, Fraser W. ;

Kothary, Rashmi .

ANNALS OF NEUROLOGY, 2012, 72 (02) :256-268

[5] Early Cost-Effectiveness of Onasemnogene Abeparvovec-xioi (Zolgensma) and Nusinersen (Spinraza) Treatment for Spinal Muscular Atrophy I in The Netherlands With Relapse Scenarios [J].

Broekhoff, Thomas F. ;

Sweegers, Carly C. G. ;

Krijkamp, Eline M. ;

Mantel-Teeuwisse, Aukje K. ;

Leufkens, Hubert G. M. ;

Goettsch, Wim G. ;

Vreman, Rick A. .

VALUE IN HEALTH, 2021, 24 (06) :759-769

[6] Large scale deletions of the 5q13 region are specific to Werdnig-Hoffmann disease [J].

Burlet, P ;

Burglen, L ;

Clermont, O ;

Lefebvre, S ;

Viollet, L ;

Munnich, A ;

Melki, J .

JOURNAL OF MEDICAL GENETICS, 1996, 33 (04) :281-283

[7] Genomic Variability in the Survival Motor Neuron Genes (SMN1 and SMN2): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development [J].

Butchbach, Matthew E. R. .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)

[8] MYOSTATIN INHIBITOR ACE-031 TREATMENT OF AMBULATORY BOYS WITH DUCHENNE MUSCULAR DYSTROPHY: RESULTS OF A RANDOMIZED, PLACEBO- CONTROLLED CLINICAL TRIAL [J].

Campbell, Craig ;

Mcmillan, Hugh J. ;

Mah, Jean K. ;

Tarnopolsky, Mark ;

Selby, Kathryn ;

Mcclure, Ty ;

Wilson, Dawn M. ;

Sherman, Matthew L. ;

Escolar, Diana ;

Attie, Kenneth M. .

MUSCLE & NERVE, 2017, 55 (04) :458-464

[9] Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study [J].

Chabanon, Aurelie ;

Seferian, Andreea Mihaela ;

Daron, Aurore ;

Pereon, Yann ;

Cances, Claude ;

Vuillerot, Carole ;

De Waele, Liesbeth ;

Cuisset, Jean-Marie ;

Laugel, Vincent ;

Schara, Ulrike ;

Gidaro, Teresa ;

Gilabert, Stephanie ;

Hogrel, Jean-Yves ;

Baudin, Pierre-Yves ;

Carlier, Pierre ;

Fournier, Emmanuel ;

Lowes, Linda Pax ;

Hellbach, Nicole ;

Seabrook, Timothy ;

Toledano, Elie ;

Annoussamy, Melanie ;

Servais, Laurent .

PLOS ONE, 2018, 13 (07)

[10] Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy [J].

Chen, T. -H. ;

Chang, J. -G. ;

Yang, Y. -H. ;

Mai, H. -H. ;

Liang, W. -C. ;

Wu, Y. -C. ;

Wang, H. -Y. ;

Huang, Y. -B. ;

Wu, S. -M. ;

Chen, Y. -C. ;

Yang, S. -N. ;

Jong, Y. -J. .

NEUROLOGY, 2010, 75 (24) :2190-2197

← 1 2 3 4 5 6 7 8 9 →